Aspen Aerogels (NYSE:ASPN) Given New $13.00 Price Target at Barclays

Aspen Aerogels (NYSE:ASPN) had its price target trimmed by Barclays from $25.00 to $13.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the construction company’s stock.

A number of other brokerages have also recently issued reports on ASPN. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. StockNews.com raised Aspen Aerogels to a “sell” rating in a research report on Wednesday. Craig Hallum cut their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. Finally, Roth Mkm cut their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels presently has an average rating of “Moderate Buy” and a consensus target price of $22.44.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $8.32 on Wednesday. The company’s fifty day moving average price is $11.85 and its 200-day moving average price is $18.22. The stock has a market cap of $682.38 million, a PE ratio of 51.98 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, equities analysts expect that Aspen Aerogels will post 0.46 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of ASPN. Lord Abbett & CO. LLC bought a new position in shares of Aspen Aerogels in the 3rd quarter worth approximately $10,126,000. Oppenheimer & Co. Inc. raised its position in Aspen Aerogels by 167.2% in the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock worth $2,839,000 after acquiring an additional 64,154 shares during the period. Sanders Morris Harris LLC boosted its stake in shares of Aspen Aerogels by 337.5% during the 4th quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock worth $436,000 after acquiring an additional 27,000 shares during the last quarter. Penserra Capital Management LLC bought a new stake in shares of Aspen Aerogels during the 3rd quarter valued at $1,342,000. Finally, Geode Capital Management LLC increased its stake in shares of Aspen Aerogels by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.